Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors and antidiabetic agents. Its structure supports the formation of bioactive molecules by providing a stable, fluorinated pyrrolidine scaffold that enhances metabolic stability and binding affinity. Commonly employed in medicinal chemistry for constructing peptidomimetics and CNS-active drugs due to favorable pharmacokinetic properties. Also utilized in the preparation of protease inhibitors and targeted therapies where selective fluorination improves drug performance.